GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Akorn, Inc. (AKRX) [hlAlert]

Rating:
Mkt Outperform
AKRX
up 1,191.84 %

Akorn, Inc. (AKRX) rated Mkt Outperform with price target $8 by Rodman & Renshaw

Posted on: Monday,  Nov 8, 2010  9:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Akorn, Inc. (NASDAQ: AKRX) on 11/08/2010. Previously Rodman & Renshaw rated Mkt Outperform Akorn, Inc. (NASDAQ: AKRX)
on 07/15/2010., when the stock price was $3.19. Since then, Akorn, Inc. has gained 1191.85% as of 01/22/2016's recent price of $41.21.
If you would have followed the previous Rodman & Renshaw's recommendation on AKRX, you would have gained 1191.84% of your investment in 2017 days.

Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations and other pharmaceutical companies. It has a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in Somerset, New Jersey and is involved in manufacturing, product development, and administrative activities related to its ophthalmic and hospital drugs & injectables segments. The Company operates in four segments: ophthalmic, hospital drugs & injectables, biologics & vaccines and contract services.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/8/2010 9:25 AM Buy
None
5.30 8.00
as of 12/31/2010
1 Week down  -13.93 %
1 Month down  -1.12 %
3 Months up  29.95 %
1 YTD down  -0.94 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/15/2010 8:25 AM Buy
None
3.19 5.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy